Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04631601
Title Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | AUS


No variant requirements are available.